NEW YORK (GenomeWeb) – Globavir Biosciences announced today that Bio-Rad Laboratories will license its PCR-based detection technology and assay for dengue virus detection.

Globavir's PanGlob assay improves diagnostic sensitivity and efficacy across four dengue serotypes, and it displays enhanced specificity for dengue over related viruses, the firm said. Globavir has obtained rights to develop and commercialize a dengue diagnostic test platform developed at Stanford University. Its diagnostic kits have received CE-mark approval.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.